Henry Schein, Inc. (NASDAQ:HSIC) – Investment analysts at William Blair cut their Q3 2017 earnings per share (EPS) estimates for shares of Henry Schein in a report issued on Wednesday. William Blair analyst J. Kreger now expects that the company will post earnings of $1.75 per share for the quarter, down from their prior estimate of $1.77. William Blair also issued estimates for Henry Schein’s Q4 2017 earnings at $1.99 EPS and FY2020 earnings at $9.79 EPS.

A number of other equities research analysts have also recently weighed in on the stock. Zacks Investment Research cut shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Wednesday. Northcoast Research upgraded shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price objective on the stock in a report on Monday. BidaskClub cut shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Wednesday, August 2nd. Jefferies Group LLC restated a “hold” rating and issued a $177.00 price objective on shares of Henry Schein in a report on Friday, July 21st. Finally, Credit Suisse Group restated a “hold” rating and issued a $160.00 price objective on shares of Henry Schein in a report on Thursday, July 13th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and seven have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $185.56.

TRADEMARK VIOLATION NOTICE: “Q3 2017 EPS Estimates for Henry Schein, Inc. Reduced by William Blair (HSIC)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/10/q3-2017-eps-estimates-for-henry-schein-inc-reduced-by-william-blair-hsic.html.

Henry Schein (NASDAQ:HSIC) opened at 169.65 on Thursday. The company has a 50-day moving average of $182.39 and a 200 day moving average of $175.07. The company has a market cap of $13.46 billion, a PE ratio of 25.78 and a beta of 1.09. Henry Schein has a 12 month low of $146.23 and a 12 month high of $186.99.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, August 8th. The company reported $1.75 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.73 by $0.02. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The business had revenue of $3.06 billion for the quarter, compared to analysts’ expectations of $3.05 billion. During the same quarter last year, the firm earned $1.64 EPS. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year.

Hedge funds and other institutional investors have recently modified their holdings of the company. Fiduciary Trust Co. increased its position in shares of Henry Schein by 16.1% in the second quarter. Fiduciary Trust Co. now owns 2,527 shares of the company’s stock valued at $462,000 after buying an additional 350 shares in the last quarter. Meiji Yasuda Life Insurance Co increased its position in shares of Henry Schein by 10.4% in the second quarter. Meiji Yasuda Life Insurance Co now owns 2,130 shares of the company’s stock worth $390,000 after buying an additional 200 shares during the period. Bradley Foster & Sargent Inc. CT increased its position in shares of Henry Schein by 2.1% in the second quarter. Bradley Foster & Sargent Inc. CT now owns 33,106 shares of the company’s stock worth $6,059,000 after buying an additional 690 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in shares of Henry Schein by 0.3% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,894 shares of the company’s stock worth $1,079,000 after buying an additional 19 shares during the period. Finally, Banque Pictet & Cie SA increased its position in shares of Henry Schein by 22.4% in the second quarter. Banque Pictet & Cie SA now owns 3,000 shares of the company’s stock worth $549,000 after buying an additional 550 shares during the period. Hedge funds and other institutional investors own 90.87% of the company’s stock.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.